SLC12A2 and glioma: Moreover, a diuretic drug, bumetanide was shown to inhibit NKCC1 in GB, resulting in reduced migration of glioma cells in vitro, decreased invasion of peritumor tissue in vivo, and increased tumor cell apoptosis [105,106].